WuXi AppTec files complaint against U.S. DoD for linking it to Chinese military
WuXi AppTec Recognized as a Top-Performing Company on 2026 Dow Jones Best-in-Class World Index
WuXi AppTec Co., Ltd. (WUXAY) Q4 2025 Earnings Call Transcript
WuXi AppTec Co., Ltd. (WUXAY) Presents at 44th Annual J.P.
WuXi AppTec (OTCMKTS:WUXIF) Shares Up 1.6% – Time to Buy?
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Award in the CRDMO Industry
China's Corporate Pivots: Alibaba's Food Delivery Gambit and WuXi AppTec's Geopolitical Hedge
WuXi AppTec Implements Its First Interim Dividend Plan, Distributing RMB1.03 Billion in Cash Dividends
WuXi AppTec Completes Second RMB1.0 Billion A-Share Repurchase Program in 2025, All Repurchased Shares to Be Cancelled
WuXi AppTec Named Constituent of the FTSE4Good Index Series for Third Consecutive Year
China's Wuxi Apptec to raise over $980 million to boost expansion
WuXi AppTec Co., Ltd. (WUXIF) Q2 2025 Earnings Call Transcript
WuXi AppTec Issues Positive Profit Alert for the First Half of 2025
WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities
WuXi AppTec Nantong Site Receives 2025 Architizer A+Award for Its Unique Blend of Technology and Humanity
WuXi AppTec Earns SBTi Validation for Near-Term Emissions Reduction Targets
Focus: China pharma projects disrupted by Sino-US tensions
WuXi AppTec Recognized by Extel 2025 Asia Executive Team Rankings with Top Honors
WuXi AppTec Co., (WUXIF) Ltd. Q1 2025 Earnings Call Transcript
WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI)
WuXi AppTec's Couvet Site Receives EcoVadis 2024 Silver Medal Rating
WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year
Despite External Challenges, WuXi AppTec Revenue and Profit Continued to Grow QoQ in the First Three Quarters of 2024; the Third Quarter Revenue Back to RMB 10+ Billion, Up 14.6% YoY Excluding COVID-19 Commercial Projects; Backlog Up 35.2% YoY
WuXi AppTec to raise $500 mln in convertible bond sale as US restrictions loom
US bill to restrict business with China's WuXi AppTec, BGI passes House
US House committee to vote on bill to restrict BGI, WuXi AppTec
U.S. bill to restrict WuXi AppTec, other Chinese biotech cos revised to give more time to cut ties
Exclusive: China's WuXi AppTec shared US client's data with Beijing, US intelligence officials told senators
US Senate committee takes up bill targeting China's BGI, WuXi Apptec
China's WuXi AppTec says it poses no national security risks to US